Zurueck zur Suche

Reporte zur Charge UT7681LA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

20Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
MI 5 CT 3 KS 2 FL 2 TX 2 VT 2 IN 1 KY 1 MA 1 MO 1

VAERS 2493535

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681La

schwer
Staat
KS
Alter
15,0
Geschlecht
M
Eingang
30.10.2022
Impfdatum
30.10.2022
Beginn
30.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Face injury Facial bones fracture Loss of consciousness

Symptomtext

Patient was given an fluzone quad and Tdap. He was in the waiting area and stood up to go to the bathroom approximately 2 min after receiving his vaccinations. He took about 5 steps and passed out, hitting his face on the concrete. He was out for a short period and when we woke, he was aware of his surroundings and could answer basic questions. I believe he experienced vasovagal syncope. He appeared to have a broken nose from hitting the concrete and his parents were going to take him to the ER. I will follow up with family tonight to see if any addition issues occurred.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
n/a at this time
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
unknown
Allergien
no
Vorherige Impfungen
-

VAERS 2467495

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

schwer
Staat
FL
Alter
30,0
Geschlecht
M
Eingang
03.10.2022
Impfdatum
01.10.2022
Beginn
01.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose Dizziness Loss of consciousness Muscle rigidity Musculoskeletal stiffness

Symptomtext

Patient arrived to the pharmacy requesting the covid vaccine (primary dose). After talking to the patient , he agreed to receive the influenza vaccine as well. Patient entered the immunization room with a friend. the 2 vaccines were administered to the patient in the right deltoid. Around half a minute of receiving the vaccine, patient said he was going to pass out and then he passed out. Patient was rigid (stiff) and his friend helped me placed the patient on the floor, while that was occurring I told my technicians to call EMS. After the patient was placed on the floor, he became awake and aware of his surroundings, that lasted less than 1 minute. He said that this always happens to him when he gets injections. EMS arrived and checked the patient and no signs of injury were observed. EMS pricked the patient finger to check his sugar and patient had the same reaction he had after receiving the vaccines. Patient then was cleared by EMS and left the pharmacy walking without need for assistance. The event was concluded to be due to his phobia to injections.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
none
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
Patient verbalized that he always have the same reaction to injections due to his fears to injections

VAERS 2597029

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge UT7681LA

mild
Staat
MI
Alter
16,0
Geschlecht
F
Eingang
21.03.2023
Impfdatum
27.02.2023
Beginn
27.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Erythema Hypoaesthesia Injection site indentation Injection site pain Peripheral swelling Injection site atrophy Injection site pruritus Injection site swelling Sensitive skin

Symptomtext

Swelling of arm and redness, pain in injection site . Now a dent , sunk in spot on left upper arm, numbness that comes and goes , as well as pain very sensitive spot in arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site atrophy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2494988

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

mild
Staat
IN
Alter
73,0
Geschlecht
F
Eingang
01.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Muscle tightness Myalgia

Symptomtext

sore muscles/tightness around back and upper shoulders night of vaccination and continued for 2 days per patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
none
Vorgeschichte
no spleen
Andere Medikamente
unknown
Allergien
na
Vorherige Impfungen
-

VAERS 2485230

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

mild
Staat
KS
Alter
46,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
15.10.2022
Beginn
16.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Immunisation reaction

Symptomtext

Pt became light headed and dizzy the next morning upon rising. Pt went to ER with daughter that experienced same SE and were checked out and all other issues were ruled out. Pt was told it most likely related to vaccinations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none that contributed
Allergien
NKA
Vorherige Impfungen
-

VAERS 2482147

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

mild
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Child said he felt faint, told him to sit for 30 minutes and gave water

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481893

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

mild
Staat
TX
Alter
5,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
14.10.2022
Beginn
15.10.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Influenza A virus test negative Influenza B virus test Ocular hyperaemia Pyrexia Rhinorrhoea Streptococcus test negative

Symptomtext

Mother of patient calling call center reported child was seen in clinic on 10/14/22 and states Saturday woke up with his eyes all red. States white of eyes have remained red since then and also has a little bit of runny nose and low-grade fever on Saturday. MOC states school nurse just called her to pick child up for red eyes and to take child to be seen by provider. Mother of child gave Motrin Patient was scheduled appointment with PCP where patient was tested for flu and strep. Medication as prescribed antibiotic Cefdinir, olopatadine solution, Cetirizine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
RAPID INFLUENZA A/B, -Negative (10/18/2022) STREP A- Negative (10/18/2022)
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2473630

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

mild
Staat
VT
Alter
17,0
Geschlecht
F
Eingang
10.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Feeling hot Vomiting

Symptomtext

Patient post vaccinations c/o feeling warm and lightheaded, patient vomited x1 with resolution of symptoms. Patient was offered water and was continuously monitored. HR 76 strong/regular 1306 All symptoms resolved

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2612392

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
MI
Alter
13,0
Geschlecht
F
Eingang
10.04.2023
Impfdatum
06.03.2023
Beginn
06.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

PROQUAD ADMINISTERED TO 13 YEAR OLD.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE REPORTED
Vorgeschichte
NONE REPORTED
Andere Medikamente
UNKNOWN
Allergien
NO KNOWN ALLERGIES
Vorherige Impfungen
-

VAERS 2536813

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
MI
Alter
16,0
Geschlecht
M
Eingang
19.12.2022
Impfdatum
01.12.2022
Beginn
06.12.2022
Tage bis Beginn
5,0
Dosis
N/A
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event

Symptomtext

On 12/6/22, patient received 1 dose of Trumenba and 1 dose of Bexsero, but he should have only received one or the other. There have been no known adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2520880

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
MI
Alter
9,0
Geschlecht
M
Eingang
01.12.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

The moderna dose that was administered on 11/21 was from a lot that had expired on 11/17. There have been no known adverse reactions. The manufacturer has been contacted for viability. The patient will continue the primary series as recommended, so he will receive his second dose in at least one month from 11/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2501361

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
CT
Alter
4,0
Geschlecht
M
Eingang
08.11.2022
Impfdatum
03.10.2022
Beginn
22.10.2022
Tage bis Beginn
19,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

an extra dose of FLUZONE QUADRIVALENT was accidently administer with no reported adverse event; Initial information received on 28-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 years old male patient had an extra dose of fluzone quadrivalent accidently administered with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (KINRIX) for Immunisation. On 03-Oct-2022, the patient received 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (formulation and strength not reported; lot UT7681LA) via intramuscular route in unknown administration site for prophylactic vaccination. On 22-Oct-2022 he also received 0.5 mL dose of the same vaccine (formulation and strength not reported; lot UT7695MA) via intramuscular route in unknown administration site for prophylactic vaccination. On 22-Oct-2022, the patient had an extra dose of fluzone quadrivalent was accidently administered with no reported adverse event (extra dose administered) (latency: same day of dose 2) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. It was reported, a patient who received 2 doses of FLUZONE QIV syringe. 1st dose received on 03-Oct-2022 and 2nd dose was received on 22-Oct-2022. An extra dose of FLUZONE QUADRIVALENT was accidently administer to a patient. This situation is reported as a medication error due to the patient receiving 2 doses of the vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
KINRIX
Allergien
-
Vorherige Impfungen
-

VAERS 2501355

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
CT
Alter
0,3
Geschlecht
F
Eingang
08.11.2022
Impfdatum
26.10.2022
Beginn
26.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

fluzone qiv np being administered to a patient under 6 months of age with no reported adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 3 months old female patient who recieved fluzone qiv np being administered to a patient under 6 months of age with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) for Prophylactic vaccination; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Prophylactic vaccination; ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Prophylactic vaccination; and HIB VACCINE CONJ (OMPC) (PEDVAXHIB) for Prophylactic vaccination. On 26-Oct-2022, the patient received 0.5 mL total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE once (formulation and strength not reported; lot UT7681LA and expiry date: 30-Jun-2023) via intramuscular route in the left thigh for prophylactic vaccination. On 26-Oct-2022, (latency: same day) the fluzone qiv np being administered to a patient under 6 months of age with no reported adverse event (product administered to patient of inappropriate age) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PEDIARIX; PREVNAR 13; ROTATEQ; PEDVAXHIB
Allergien
-
Vorherige Impfungen
-

VAERS 2489984

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
CT
Alter
0,3
Geschlecht
F
Eingang
26.10.2022
Impfdatum
26.10.2022
Beginn
26.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient came to office for 3 month exam. Received all of her 3 month. Per provider mom requested flu vaccine as well. Flu vaccine administered into left thigh and tolerated it well. Pt remained in the office for 10 or so minutes following vaccination and showed no s/s of reaction. Mom notified that vaccine was given at 3 months instead of 6.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2487409

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7681la

gering
Staat
FL
Alter
62,0
Geschlecht
F
Eingang
24.10.2022
Impfdatum
02.10.2022
Beginn
08.10.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
SARS-CoV-2 test negative

Symptomtext

Patient came and complaint that the Saturday after getting the vaccine she ended up in the hospital. She had a lot of check ups done but everything came back negative. She thought that the Pfizer vaccine gave her Covid but the hospital said she was negative for COVID.She tells me that she has a chronic condition Bronchiostasis and also, thinks that the vaccine could of exacerbated it. Outcome she told that she was going to go to her medical doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
SARS-CoV-2 test negative
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
-
Vorgeschichte
Patient tells me she has a chronic condition called bronchiostasis.
Andere Medikamente
Lisinopril 10 mg Montelukast 10 mg Atorvastatin 10 mg paroxetine 30 mg
Allergien
No allergies
Vorherige Impfungen
-

VAERS 2484163

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
MI
Alter
15,0
Geschlecht
M
Eingang
20.10.2022
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Patient was given MMRV (proQuad) after the allowed time frame of the vaccine of 12 months to 12 years. The CDC was contacted and with regards to the vaccine being administered incorrectly. The representative stated that there according to testing from the manufacture there is no issue with the vaccine being administered after the suggested time frame as long as standard MMRV vaccination standards are being followed. Documentation was provided via Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2476265

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge UT7681LA

gering
Staat
VT
Alter
9,0
Geschlecht
M
Eingang
12.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

COVID vaccine given 3 days post expiration date. No adverse event occured. PCP, dept of health notified and family notified. Awaiting advice from dept of health on validity of dose and subsequent dosing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475528

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
KY
Alter
50,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
06.10.2022
Beginn
07.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Peripheral swelling

Symptomtext

PATIENT STATES ARM IS SWOLLEN AND RED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
DOXEPIN 10MG , LOTRONEX 0.5MG, XIFAXAN 550MG
Allergien
NKA
Vorherige Impfungen
-

VAERS 2450815

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
MA
Alter
15,0
Geschlecht
M
Eingang
19.09.2022
Impfdatum
15.09.2022
Beginn
16.09.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Wrong product administered

Symptomtext

Patient, was overdue for dose 2 of primary series for manufacturer Pfizer. First dose of Pfizer primary series given 1/20/22. Patient received Pfizer Bivalent booster on 9/15/22 instead of Pfizer monovalent/dose #2 of primary series. Medical provider, Dr. and Medical Officer, Dr. both made aware of situation. Mother of patient called and notified no harm done in patient receiving bivalent booster, which includes monovalent and variant. However, it still needs to be reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A, no adverse symptoms reported to date.
Aktuelle Erkrankungen
N/A
Vorgeschichte
ADHD, learning disability, flat foot
Andere Medikamente
N/A
Allergien
Penicillin and amoxicillin
Vorherige Impfungen
-

VAERS 2446433

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7681LA

gering
Staat
MO
Alter
57,0
Geschlecht
M
Eingang
15.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Influenza like illness Local reaction Oxygen saturation decreased Swelling

Symptomtext

After getting the shot, pt had a local reaction of redness and swelling, flu-like symptoms, and decreased oxygen levels. He is no longer having these side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-